Open Access
Flavonoids, dietary antioxidant compounds may offer some protection against earlystage diabetes mellitus and its associated complications. The present study aimed to evaluate the effect of rutin on overall health of patients with diabetes mellitus. The effects of rutin were tested by using it as a supplement with their regular medications. The total trial period was of 120 days conducted with a gap of 30 days each. It consisted of 30 patients aging between 40-50 years, having diabetes mellitus since last 5 years. These patients were given Rutin Tablets for 60 days. Fasting Blood Sugar (FBS), Body Mass Index (BMI), blood pressures, lipid profile, serum urea and creatinine, electrolytes, SGOT (serum glutamic oxaloacetic transaminase), SGPT (serum glutamic pyruvic transaminase) and Alkaline phosphatase (ALP) were measured at baseline and then after every 30 days. Rutin tablets were stopped for next 60 days. All of above parameters were again measured on 90th and 120th day. The results showed that rutin decreased the levels of FBS, systolic and diastolic blood pressure, HDL, Serum Urea and creatinine significantly (P<0.05), whereas significant increase (P<0.05) in TGL, HDL, VLDL were seen. Decrease in the level of SGOT, SGPT, ALP and BMI is not significant.
Year
Month
Radical scavenging activities of the leaf extracts and a flavonoid glycoside isolated from Cineraria abyssinica Sch. Bip. Exa. Rich
Biruk Sintayehu, Kaleab Asres, Y. RaghavendraHepatoprotective Activity of Methanolic Extract of Rhyncosia Beddomei Baker Leaves Against Carbon Tetrachloride Induced Hepatotoxicity
Soluble Curcumin: A Promising Oral Supplement For Health Management
Puneet Gandhi, Zeba Khan, Nivedita Chakraverty